Knowledge levels and community guidance of doctors working in family health centers on HPV screening and HPV vaccination.
cervical cancer
human papillomavirus
vaccine
Journal
The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
25
03
2023
accepted:
10
07
2023
medline:
23
10
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
ppublish
Résumé
Our aim is to evaluate the level of knowledge, compliance with the screening program, and tendency to inform patients of the doctors working in FHCs where HPV testing is performed within the scope of the cervical cancer screening program in our country. This cross-sectional study was performed between June and September 2022 with 113 family physicians working in different FHCs in different provinces in Turkey. Questionnaires prepared by the researchers were delivered to family physicians via online platforms. When the different age groups were evaluated, in two of the 24 knowledge-level questions (How many types of HPV are there? Can HPV infect men?) the rate of correct answers for participants under the age of 35 years was statistically significantly higher (p = 0.007; p = 0.032). With regard to professional experience, the group with fewer than 10 years of experience gave a statistically significant correct answer to two questions (How many types of HPV are there? Can HPV infect men?; p = 0.008; p = 0.037). It was observed that 107 (94.7%) of the 113 family physicians who participated in the survey recommended that their patients use condoms during intercourse, 110 (97.3%) recommended cervical cancer screening tests to patients who applied for another reason, 105 (92.9%) recommended the HPV vaccine to patients and their relatives and 60 (53.1%) recommended the HPV vaccine to patients who applied for another reason. The success of HPV vaccination programs is directly related to the beliefs of health personnel and their recommendations to the general population.
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2519-2527Informations de copyright
© 2023 Japan Society of Obstetrics and Gynecology.
Références
Dong Z, Hu R, Du Y, Tan L, Li L, Du J, et al. Immunodiagnosis and Immunotherapeutics based on human papillomavirus for HPV-induced cancers. Front Immunol. 2021;8(11):586796. https://doi.org/10.3389/fimmu.2020.586796
Ciavattini A, Giannella L, De Vincenzo R, Di Giuseppe J, Papiccio M, Lukic A, et al. HPV vaccination: the position paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV). Vaccines (Basel). 2020;8(3):354. https://doi.org/10.3390/vaccines8030354
Giannella L, Giorgi Rossi P, Delli Carpini G, Di Giuseppe J, Bogani G, Gardella B, et al. Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3. Gynecol Oncol. 2021;161(3):741-747. https://doi.org/10.1016/j.ygyno.2021.03.025
Gupta SM, Mania-Pramanik J. Molecular mechanisms in progression of HPV-associated cervical carcinogenesis. J Biomed Sci. 2019;26(1):28-50. https://doi.org/10.1186/s12929-019-0520-2
Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical cancer screening: past, present, and future. Sex Med Rev. 2020;8(1):28-37. https://doi.org/10.1016/j.sxmr.2019.09.005
National Cancer Institute. Human papillomavirus (HPV) vaccines. National Institute of Health. 2019 https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-and-cancer. Accessed 2020 Oct 12.
Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019;68:698-702. https://doi.org/10.15585/mmwr.mm6832a3
Food and Drug Administration. FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. 2018 https://www.fda.gov/news-events/press-announcements/fda-approves-expanded-use-gardasil-9-include-individuals-27-through-45-years-old#:~:text=TheU.S.%2. Accessed 2020 Oct 12
Rashid S, Labani S, Das BC. Knowledge, awareness and attitude on HPV, HPV vaccine and cervical cancer among the college students in India. PloS One. 2016;11(11):e0166713.
Buskwofie A, David-West G, Clare CA. A review of cervical cancer: incidence and disparities. J Natl Med Assoc. 2020;112(2):229-232. https://doi.org/10.1016/j.jnma.2020.03.002
Görkem Ü, Toğrul C, İnal HA, Salman Özgü B, Güngör T. Üniversite hastanesinde çalışan yardımcı sağlık personelinin Human Papilloma Virüs ve aşısı hakkında bilgi düzeyleri ve tutumları. 2015.
Tayfur ÇİFT, Korkmazer E, Temur M, Karataş S, Özdemir H, Güçlü T, et al. Hastanede çalışan ebe ve hemşirelerin Human Papilloma Virüs aşıları hakkında bilgi ve tutumlarının değerlendirilmesi. Ankara Eğitim Ve Araştırma Hastanesi Tıp Dergisi. 2019;52(1):49-52.
Keten HS, Ucer H, Dalgaci AF, Isik O, Ercan Ö, Guvenc N. Knowledge, attitude, and behavior of teachers regarding HPV (human papillomavirus) and vaccination. J Cancer Educ. 2021;36(3):584-590.
Smolarczyk K, Pieta W, Majewski S. Assessment of the state of knowledge about HPV infection and HPV vaccination among polish resident doctors. Int J Environ Res Public Health. 2021;18(2):551.
Jain N, Irwin KL, Montano D, Kasprzyk D, Carlin L, Freeman C, et al. Family physicians' knowledge of genital human papillomavirus (HPV) infection and HPV-related conditions, United States, 2004. Fam Med. 2006;38(7):483.